Filing Details

Accession Number:
0000932440-16-000387
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-16 17:41:27
Reporting Period:
2016-05-12
Filing Date:
2016-05-16
Accepted Time:
2016-05-16 16:41:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
827871 Eagle Pharmaceuticals Inc. EGRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1033508 Jay Moorin C/O Proquest Investments
2430 Vanderbilt Beach Road, #108 - 190
Naples FL 34109
Yes No Yes No
1225149 Alain Schreiber C/O Proquest Investments
2430 Vanderbilt Beach Road, #108 - 190
Naples FL 34109
Yes No Yes No
1379010 Proquest Management Llc
2430 Vanderbilt Beach Road, #108 - 190
Naples FL 34109
No No Yes No
1431818 Proquest Investments Iv, L.p.
2430 Vanderbilt Beach Road, #108 - 190
Naples FL 34109
No No Yes No
1431819 Proquest Associates Iv Llc
2430 Vanderbilt Beach Road, #108 - 190
Naples FL 34109
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Disposition 2016-05-12 4,000 $40.00 55,061 No 4 S Indirect By ProQuest Management LLC Plans
Common Stock $0,001 Par Value Disposition 2016-05-13 13,980 $40.92 41,081 No 4 S Indirect By ProQuest Management LLC Plans
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By ProQuest Management LLC Plans
No 4 S Indirect By ProQuest Management LLC Plans
Footnotes
  1. The shares are held in a ProQuest Management LLC Defined Benefit Pension Plan ("DBPP") FBO Jay Moorin and a ProQuest Management LLC Salary Savings Plan FBO Jay Moorin and for the benefit of certain other individuals. Jay Moorin and Alain Schreiber are trustees of ProQuest Management LLC DBPP FBO Jay Moorin and the ProQuest Management LLC Salary Savings Plan FBO Jay Moorin and for the benefit of certain other individuals. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of each Reporting Person's pecuniary interest in such securities.
  2. Consists of shares sold by DBPP.